Duquesne
INSM · Medicine & biotech

Insmed

Makes medicines for serious lung diseases.
New: first time
Option
Duquesne holds call options on Insmed: contracts that pay off if its price goes up. They cover 1.4 million shares, worth about $144 million. They bought them for the first time between April and June.
Mar 31
None
Jun 30
1,350,000

The numbers

Shares it covers
1,350,000
Value of the shares it covers
$143,937,000
about $144 million
Share of their money
Not counted
Options aren’t part of their stock money
Kind
Call option: a bet the price goes up
Also owned by
No other fund we follow
They also hold Insmed as shares.
More about Insmed
The value uses the price on Jun 30, 2026. The fund may have paid a different price.
Not investment advice. Holdings come from public SEC reports and the funds’ own letters, and can be up to 4½ months old. How this works